China National Accord Medicines Corp Ltd (200028) - Total Liabilities
Based on the latest financial reports, China National Accord Medicines Corp Ltd (200028) has total liabilities worth HK$27.21 Billion HKD (≈ $3.47 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
China National Accord Medicines Corp Ltd - Total Liabilities Trend (1992–2025)
This chart illustrates how China National Accord Medicines Corp Ltd's total liabilities have evolved over time, based on quarterly financial data. See China National Accord Medicines Corp Ltd (200028) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
China National Accord Medicines Corp Ltd Competitors by Total Liabilities
The table below lists competitors of China National Accord Medicines Corp Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
RiverNorth Managed Duration Municipal Income Fund II Inc.
NYSE:RMMZ
|
USA | $92.06 Million |
|
GENOR BIOPHARMA DL-00002
F:67N0
|
Germany | €226.09 Million |
|
Coast Entertainment Holdings Ltd
AU:CEH
|
Australia | AU$40.16 Million |
|
ATEME SA
PA:ATEME
|
France | €76.74 Million |
|
Bigtincan Holdings Ltd
AU:BTH
|
Australia | AU$94.00 Million |
|
Mnc Kapital Indonesia Tbk
JK:BCAP
|
Indonesia | Rp24.08 Trillion |
|
Kyungin Synthe
KO:012610
|
Korea | ₩261.79 Billion |
|
Ubiquoss Inc
KQ:264450
|
Korea | ₩30.50 Billion |
Liability Composition Analysis (1992–2025)
This chart breaks down China National Accord Medicines Corp Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of China National Accord Medicines Corp Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how China National Accord Medicines Corp Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for China National Accord Medicines Corp Ltd (1992–2025)
The table below shows the annual total liabilities of China National Accord Medicines Corp Ltd from 1992 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | HK$27.47 Billion ≈ $3.51 Billion |
+2.50% |
| 2024-12-31 | HK$26.80 Billion ≈ $3.42 Billion |
+0.78% |
| 2023-12-31 | HK$26.59 Billion ≈ $3.39 Billion |
+14.77% |
| 2022-12-31 | HK$23.17 Billion ≈ $2.96 Billion |
-6.42% |
| 2021-12-31 | HK$24.76 Billion ≈ $3.16 Billion |
+9.05% |
| 2020-12-31 | HK$22.71 Billion ≈ $2.90 Billion |
+25.03% |
| 2019-12-31 | HK$18.16 Billion ≈ $2.32 Billion |
+20.87% |
| 2018-12-31 | HK$15.02 Billion ≈ $1.92 Billion |
+21.01% |
| 2017-12-31 | HK$12.42 Billion ≈ $1.58 Billion |
+0.14% |
| 2016-12-31 | HK$12.40 Billion ≈ $1.58 Billion |
+62.04% |
| 2015-12-31 | HK$7.65 Billion ≈ $976.79 Million |
-4.08% |
| 2014-12-31 | HK$7.98 Billion ≈ $1.02 Billion |
-8.73% |
| 2013-12-31 | HK$8.74 Billion ≈ $1.12 Billion |
+17.23% |
| 2012-12-31 | HK$7.46 Billion ≈ $951.89 Million |
+19.52% |
| 2011-12-31 | HK$6.24 Billion ≈ $796.43 Million |
+20.55% |
| 2010-12-31 | HK$5.18 Billion ≈ $660.65 Million |
+18.83% |
| 2009-12-31 | HK$4.36 Billion ≈ $555.98 Million |
+43.52% |
| 2008-12-31 | HK$3.03 Billion ≈ $387.38 Million |
+27.05% |
| 2007-12-31 | HK$2.39 Billion ≈ $304.90 Million |
+8.26% |
| 2006-12-31 | HK$2.21 Billion ≈ $281.65 Million |
+225.07% |
| 2005-12-31 | HK$678.73 Million ≈ $86.64 Million |
+39.09% |
| 2004-12-31 | HK$487.99 Million ≈ $62.29 Million |
-26.67% |
| 2003-12-31 | HK$665.47 Million ≈ $84.95 Million |
-7.30% |
| 2002-12-31 | HK$717.90 Million ≈ $91.64 Million |
-4.75% |
| 2001-12-31 | HK$753.72 Million ≈ $96.21 Million |
+778.18% |
| 2000-12-31 | HK$85.83 Million ≈ $10.96 Million |
-1.03% |
| 1999-12-31 | HK$86.72 Million ≈ $11.07 Million |
-24.01% |
| 1998-12-31 | HK$114.11 Million ≈ $14.57 Million |
-31.94% |
| 1997-12-31 | HK$167.66 Million ≈ $21.40 Million |
+87.37% |
| 1996-12-31 | HK$89.48 Million ≈ $11.42 Million |
+77.00% |
| 1995-12-31 | HK$50.55 Million ≈ $6.45 Million |
-11.09% |
| 1994-12-31 | HK$56.85 Million ≈ $7.26 Million |
-41.32% |
| 1993-12-31 | HK$96.88 Million ≈ $12.37 Million |
+4.01% |
| 1992-12-31 | HK$93.14 Million ≈ $11.89 Million |
-- |
About China National Accord Medicines Corp Ltd
China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers new and special drugs and medications for chronic diseases. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources, as well as chemical drugs, OTC drugs, and healt… Read more